The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
 
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Takeda
HORIZON (OP-106): An exploratory analysis of time-to-next treatment (TTNT) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) who received melflufen plus dexamethasone (dex).
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pharmamar-zeltia; Takeda
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Celgene
 
Alessandra Larocca
No Relationships to Disclose
 
Joan Blade
No Relationships to Disclose
 
Michele Cavo
No Relationships to Disclose
 
Paula Rodríguez Otero
Consulting or Advisory Role - Abbvie; Celgene; Janssen; Kite, a Gilead company; Sanofi
Speakers' Bureau - Amgen; Celgene; Janssen
Travel, Accommodations, Expenses - Celgene
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Janssen-Cilag; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Oncopeptides; Pierre Fabre; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Gilead Sciences; Janssen-Cilag; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Oncopeptides; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
John W. Hiemenz
Consulting or Advisory Role - Cadence Research and Consulting; Integra LifeSciences
Travel, Accommodations, Expenses - Integra LifeSciences
 
Hani Hassoun
Consulting or Advisory Role - Novartis
Research Funding - Celgene; Janssen; Takeda
 
Cyrille Touzeau
Honoraria - Abbvie; Amgen; Celgene; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Novartis
Research Funding - Abbvie (Inst)
 
Adrian Alegre
Consulting or Advisory Role - Amgen; Celgene; Janssen; Sanofi; Takeda
Speakers' Bureau - Celgene; Janssen; Janssen
Research Funding - Amgen; Celgene; Janssen; Sanofi
 
Agne Paner
Honoraria - Amgen; Celgene; Janssen
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Takeda
 
Christopher Maisel
Honoraria - See CMS open payments website for details.
Speakers' Bureau - See CMS open payments website for details.
 
Amitabha Mazumder
No Relationships to Disclose
 
Anastasios Raptis
Consulting or Advisory Role - Cadence Research and Consulting; Integra LifeSciences
Travel, Accommodations, Expenses - Integra LifeSciences
 
Johan Harmenberg
Leadership - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
Consulting or Advisory Role - Oncopeptides
Travel, Accommodations, Expenses - Oncopeptides
 
Stojan Zavisic
Employment - Oncopeptides
Stock and Other Ownership Interests - Intercept Pharmaceuticals; Oncopeptides
 
Sara Thuresson
Employment - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
 
Oskar Öhman
Employment - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
Travel, Accommodations, Expenses - Oncopeptides
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)